HIGHLIGHTS
- who: Bart J.A. Rijnders from the Department of Internal Medicine, Section of Infectious Diseases Erasmus MC, University Medical Center, Rotterdam, the Netherlands have published the article: Evidence-based dosing of convalescent plasma for COVID-19 in future trials, in the Journal: (JOURNAL) of 27/Dec/2021
- what: The authors focus on the former and try to provide guidance on appropriate dosing of ConvP in future trials or when ConvP is considered for the treatment of immunocompromized patients unable to clear SARSCoV-2.
- how: This study therefore confirmed that ConvP with extremely high . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.